A research team have created a new strategy for developing an effective vaccine against a widespread form of tuberculosis.
List view / Grid view
Using synthetic chemistry, researchers have fused hydrophobic adjuvants with water-soluble proteins to create a new type of vaccine.
Tested on two assays, researchers have shown that Redx03863 and Redx04739 can combat tuberculosis and do not lead to resistance.
Researchers have developed MorphEUS, a technology to identify new drugs that combat M. tuberculosis by revealing how compounds destroy the bacteria.
A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
Researchers have found that certain immune cells aid in fighting tuberculosis bacteria, providing a new drug target.
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Tuberculosis is the most deadly infectious disease in the world. Standard TB therapy takes at least 6 months and patients infected with multi-drug...